Decheng Capital

Venture Capital · Menlo Park (United States), Shanghai (China), New York (United States) · Founded 2012

About

Decheng Capital is a global life sciences investment firm providing capital and strategic support to early-stage and growth-stage healthcare companies. They focus on companies with revolutionary technologies and strong market presence. Founded in 2012, Decheng has over $2 billion in capital.

Investment Stages

Series A, Series B, Series C

Industry Focus

BioTech, Diagnostics, Healthcare, MedTech

Team (11)

Katherine Xu - Partner
Peter Colabuono - Managing Director
Qiang Xu - Partner
Dayton Misfeldt - Partner
Michael Notaras - Vice President
Min Cui - Founder and Managing Director
Tony Tong - Partner
Victor Tong - Managing Director
Yang Lu - Vice President
Aaron Li - Vice President